生命科学资讯

White House frustration may have fueled FDA’s Moderna walkback: Politico

Novartis winds down ph. 1 solid tumor program after lacking efficacy

Sanofi backs Altesa's $75M series B to bankroll antiviral's midstage rhinovirus study

Study finds blood test can predict age of Alzheimer's onset

J&J halts enrollment in phase 2 trial of AC Immune-partnered Alzheimer's therapy

GSK strikes 5-year deal with Jackson Laboratory focused on neurodegenerative disease research

NIH Director Jay Bhattacharya to take over as temporary CDC chief: media reports

Senate HELP Committee chair pitches proposals for FDA reform

Blood from pediatricians yields potential new medicines for respiratory viruses

FDA accepts filing for Moderna flu vaccine after swift rethink

Novartis finds natural partner in macrocycle biotech, inking $1.7B-plus cardio deal

Sensei steps back from brink by finding Faeth and its phase 2-stage cancer drug

Gut-focused Rasayana ingests gastrointestinal candidate in $36M licensing deal

Danaher buys patient monitoring specialist Masimo in $9.9B deal

Lilly pays CSL $100M upfront for IL-6 antibody that flunked a phase 3 organ transplant study

Korsana crosses into crowded Alzheimer's field with $175M and anti-amyloid antibody

Immunology CRO RoukenBio pens pact with AVS Bio for more predictable antibody development

Cell therapy company hopes to end Tokyo biotech IPO drought with $92M offering

Boehringer axes inhaled gene therapy after viewing cystic fibrosis data

Sanofi points to 'key opportunity' for Teva-partnered IBD in long-term data